The influence of platelet additive solutions on cytokine levels and complement activation in platelet concentrates during storage.
OBJECTIVE
The accumulation of platelet-derived cytokines in platelet concentrates (PC) during storage may contribute towards non-haemolytic transfusion reactions (NHTR). We investigated the effect of platelet storage medium on platelet activation, complement activation and cytokine levels in leucocyte-reduced PC.


METHODS
Hyperconcentrated platelets (3000-6000 x 109/l) were collected by apheresis and diluted in 100% plasma, 70% PASIII, or 70% or 80% PASIII supplemented with magnesium and potassium (PAS IIIM).


RESULTS
Levels of transforming growth factor-beta (TGF-beta) and regulated on activation, normal, T-cell expressed, and secreted (RANTES) increased during storage, as did the expression of P-selectin (CD62P), and were highest in PC stored in PASIII. In PC stored in PASIIIM, however, levels of TGF-beta and RANTES were not significantly different from PC stored in plasma. Levels of CD62P expression, however, remained higher in PASIIIM PC than in those stored in plasma by day 5, but were lower than PC stored in PASIII. C3a des arg levels increased during storage in all media with the exception of PASIII and, on day 7, were higher in PC stored in plasma compared to PC stored in the other media.


CONCLUSIONS
Our results indicate that replacing plasma in PC with unmodified PASIII for storage results in higher levels of platelet-derived cytokines in PC. Furthermore, it appears that the nature of the medium used for storage of PC has a significant impact on platelet activation and cytokine levels of the PC. These implications should be taken into account when considering replacement of plasma with PAS.
Cardigan
R
R
National Blood Service, England & North Wales, UK. rebecca.cardigan@nbs.nhs.uk
Sutherland
J
J
Wadhwa
M
M
Dilger
P
P
Thorpe
R
R
D001792:Blood Platelets / Q000187:drug effects* / Q000378:metabolism; D001793:Blood Preservation / Q000379:methods*; D003167:Complement Activation / Q000187:drug effects; D016207:Cytokines / Q000032:analysis; D006801:Humans; D010592:Pharmaceutic Aids / Q000737:chemistry / Q000494:pharmacology*; D015539:Platelet Activation / Q000187:drug effects; D017713:Platelet Transfusion / Q000592:standards*
D016207:Cytokines; D010592:Pharmaceutic Aids